ARV programme cuts AIDS deaths


This is according to the Actuarial Society of Southern Africa (ASSA), which has been tracking and modelling the HIV/AIDS epidemic for over 25 years.
According to the new ASSA model, ‘the annual number of AIDS deaths in South Africa has reduced from 257 000 in 2005 to 194 000 in 2010’, largely because of the ‘rapid expansion of the South African antiretroviral treatment programme’.
The new model, ASSA2008, estimates that last year 10.9% of the South African population was infected with HIV, with 5.5 million people living with HIV.
Based on ‘substantial increases in condom use over the last decade, which is supported by findings from recent household surveys’, ASSA2008 estimates that HIV prevalence in young people aged 15 to 24 has dropped from 9.2% in 2005 to 7.7% in 2010.
However, the society estimates that HIV prevalence in South Africans aged 15 to 49 has increased slightly from 16.4% in 2005 to 17% in 2010, partly because ‘HIV-infected adults surviving for longer due to antiretroviral treatment’.
KwaZulu-Natal, the province worst affected by HIV, had triple the HIV prevalence rate of the least affected province, the Western Cape (almost 15%). Life expectancy in KwaZulu-Natal was 10 years lower than the Western Cape, at 53.4.
Professor Rob Dorrington, the main author of ASSA2008 and Director of the Centre for Actuarial Research at the University of Cape Town, warned that it was difficult to estimate future AIDS mortality as there is ‘ much uncertainty regarding long-term survival rates after antiretroviral treatment initiation’.
The ASSA2008 model also does not take into account recently introduced HIV prevention strategies, the most significant of these being the promotion of male circumcision. This has been shown to reduce rates of heterosexual HIV transmission by around 60% among men.
Author
-
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
View all posts
Republish this article

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
ARV programme cuts AIDS deaths
by Health-e News, Health-e News
March 10, 2011
MOST READ
EDITOR'S PICKS
Related



Pit toilets in South Africa’s schools will be there long after March 31 deadline


